M.V.I.-12 LYOPHILIZED
Pre-Launchascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine; riboflavin 5'-phosphate sodium; thiamine; vitamin a; vitamin e
NDAINJECTIONINJECTABLE
Lifecycle
Pre-Launch
Data completeness
0/8 — Limited
Drug data last refreshed 2w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
M.V.I.-12 Lyophilized is a parenteral multivitamin formulation containing 12 essential vitamins (A, B-complex, C, D, E) administered via injection. It is indicated for patients requiring intravenous nutritional supplementation, particularly those unable to meet vitamin requirements orally. The product provides comprehensive micronutrient support for metabolic function and immune health.
Pre-Launch
Pre-launch stage indicates small team size with focus on regulatory completion and manufacturing scale-up rather than commercial expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
This pre-launch product offers entry-level to early-career opportunities in manufacturing science, operations, and formulation development rather than commercial roles. Career progression will depend on successful regulatory approval and supply chain execution.
Scientist IDevelopment Center Protein Development Intern
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.